Literature DB >> 16345061

Predicting the lung cancer burden: Accounting for selection of the patients with respect to general population mortality.

Sirpa Heinävaara1, Timo Hakulinen.   

Abstract

Incidence, survival, prevalence and mortality are the elements of the cancer burden. The cancer burden is thus contributed by the same individuals from the diagnosis of cancer (incidence) until possible death from cancer (mortality). It would therefore be natural that predictions of future cancer burden, those needed by health administration, for example, could be based on individual data. This paper presents a new model for estimating future cancer burden, a model where individuals are followed from birth to death with or without a diagnosis of cancer. The model can formally be expressed as a summation of log-likelihoods of getting cancer and of surviving the cancer and other causes of death until death or censoring. The new model is illustrated with data of Finnish males with or without a diagnosis of lung cancer in calendar period 1987-1997. Incidence is modelled with a general age-cohort model with a drift and survival from cancer with a parametric mixture model. In a model for survival from other causes of death, selection of patients with respect to general population mortality is accounted for. Future cancer burden is illustrated with short-term predictions of prevalence and mortality. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16345061     DOI: 10.1002/sim.2443

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Construction of pH/reduction dual responsive MSN-HAgel containing HApt for tumor targeting carriers.

Authors:  Yehong Liu; Miaoxin Chen; Gaoyang Li; Shouhong Xu; Honglai Liu
Journal:  RSC Adv       Date:  2022-06-29       Impact factor: 4.036

2.  Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry.

Authors:  Tomáš Pavlík; Ondřej Májek; Jan Mužík; Jana Koptíková; Lubomír Slavíček; Jindřich Fínek; David Feltl; Rostislav Vyzula; Ladislav Dušek
Journal:  BMC Public Health       Date:  2012-02-10       Impact factor: 3.295

3.  Projections of cancer prevalence in the United Kingdom, 2010-2040.

Authors:  J Maddams; M Utley; H Møller
Journal:  Br J Cancer       Date:  2012-08-14       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.